Results 101 to 110 of about 16,149 (262)
Comparison of different therapeutic strategies for complete hydatidiform mole in women at least 40 years old: a retrospective cohort study. [PDF]
BMC Cancer, 2017 BackgroundThere are three main therapeutic strategies, namely expectant management (dilation and curettage only), prophylactic chemotherapy and prophylactic total hysterectomy for treating older women with complete hydatidiform mole (CHM).
Zhao P, Chen Q, Lu W.
europepmc +2 more sources
Pregnancy, Volume 1, Issue 4, July 2025.Abstract Background Postpartum hemorrhage (PPH) is the leading cause of maternal morbidity and mortality globally, and PPH rates in the United States are increasing. The current study describes treatment patterns and healthcare costs in abnormal postpartum uterine bleeding and PPH in the United States. Method Utilizing data from the US Premier Hospital
Kara M. Rood +6 more
wiley +1 more source
Expression of c-myc and c-fms oncogenes in trophoblastic cells in hydatidiform mole and normal human placenta [PDF]
, 1993 Aims: To compare the expression of c-myc and c-fms proto-oncogenes in the placenta and hydatidiform mole. Methods: Twelve hydatidiform moles and six induced abortion cases were collected. c-myc and c-fms proto-oncogene expression was analysed by northern
Cheung, ANY +5 more
core +2 more sources
ENT‐1‐Targeted Polymersomes to Enhance the Efficacy of Methotrexate in Choriocarcinoma Treatment
Small Science, Volume 5, Issue 7, July 2025.ENT‐1‐targeted stimuli‐responsive polymersomes enhance the delivery and release of MTX, as demonstrated in choriocarcinoma tumors mouse model. These targeted nanocarriers improve tumor uptake and efficiently release the drug within the tumor, highlighting their potential for enhanced chemotherapy in choriocarcinoma treatment.
Babak Mamnoon +10 more
wiley +1 more source
Histological Study of Molar Pregnancy by using some of the Special Stains
Diyala Journal of Medicine, 2019 Background: Molar pregnancy (hydatidiform mole HM) is an abnormal form of pregnancy in which a non-viable fertilized egg implants in the uterus and will fail to come to term.
Tuqa Yousif Sharef +2 more
doaj +2 more sources
Ultrasound in Obstetrics &Gynecology, Volume 66, Issue 1, Page 73-80, July 2025.ABSTRACT Objectives The ultrasound diagnosis of placental site trophoblastic tumor (PSTT) is challenging owing to a lack of pathognomonic features. Differential diagnosis from other forms of gestational trophoblastic neoplasia (GTN) is critical owing to major differences in prognosis and treatment.
R. Cioffi +6 more
wiley +1 more source
Twin pregnancy with both complete hydatiform mole and coexistent alive fetus: Case report
Asian Pacific Journal of Reproduction, 2015 Twin pregnancy consisting of a complete hydatidiform mole coexisting with a live fetus is a rare condition with an incidence of 1 in 22000 to 1 in 100000 pregnancies.
Achour Radhouane +2 more
doaj +1 more source
Clinics, 2017 OBJECTIVES: Doppler ultrasonography can be used to assess neoangiogenesis, a characteristic feature of postmolar gestational trophoblastic neoplasia. However, there is limited information on whether uterine artery Doppler flow velocimetry parameters can ...
Flavia Tarabini Castellani Asmar +5 more
semanticscholar +1 more source
Investigative utility ofmicrosatlite genotyping for molar pregnancy testing [PDF]
, 2016 Hydatidiform mole also known as hydatid mole, molar pregnancy, gestational trophoblastic disease is a type of fertilization abnormality, when only the conceptus trophoblast layers proliferates and not the embryoblast, no embryo develops, this is called a
Ezugwu, Chisom Anthoinette
core
Recurrent hydatidiform mole transformed into invasive mole with co-morbid depression- a rare case report [PDF]
, 2017 The gestational trophoblastic disease is a group of interrelated lesions that arise from abnormal proliferation of placental trophoblast. It comprises of hydatidiform mole (partial or complete), invasive mole, placental site trophoblastic tumor and ...
Bhagat, Nisha, Raj, Rajnish
core +2 more sources